These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6147891)

  • 1. Developing and maintaining adherence to long-term drug-taking regimens.
    Falloon IR
    Schizophr Bull; 1984; 10(3):412-7. PubMed ID: 6147891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding and addressing adherence issues in schizophrenia: from theory to practice.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 14():14-9. PubMed ID: 18284273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.
    Donohoe G; Owens N; O'Donnell C; Burke T; Moore L; Tobin A; O'Callaghan E
    Eur Psychiatry; 2001 Aug; 16(5):293-8. PubMed ID: 11514132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health beliefs and compliance with antipsychotic medication.
    Budd RJ; Hughes IC; Smith JA
    Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual reality assessment of medication compliance in patients with schizophrenia.
    Baker EK; Kurtz MM; Astur RS
    Cyberpsychol Behav; 2006 Apr; 9(2):224-9. PubMed ID: 16640484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compliance problems in treatment of schizophrenic patients].
    Barnas C; Hummer M; Fleischhacker WW
    Wien Med Wochenschr; 1998; 148(11-12):281-3. PubMed ID: 9746971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a structural model explaining medication compliance of persons with schizophrenia.
    Seo MA; Min SK
    Yonsei Med J; 2005 Jun; 46(3):331-40. PubMed ID: 15988803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings.
    Kampman O; Lehtinen K; Lassila V
    Acta Psychiatr Scand; 2001 Oct; 104(4):299-304. PubMed ID: 11722305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining and assessing adherence to oral antipsychotics: a review of the literature.
    Velligan DI; Lam YW; Glahn DC; Barrett JA; Maples NJ; Ereshefsky L; Miller AL
    Schizophr Bull; 2006 Oct; 32(4):724-42. PubMed ID: 16707778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic review of compliance with medication therapy in the treatment of schizophrenia.
    Thieda P; Beard S; Richter A; Kane J
    Psychiatr Serv; 2003 Apr; 54(4):508-16. PubMed ID: 12663838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Jan; 16(1):34-45. PubMed ID: 20098229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adherence to antipsychotic medication in schizophrenia patients].
    Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D
    Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicine taking decisions: schizophrenia in comparison to asthma and epilepsy.
    Marland GR; Cash K
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):163-72. PubMed ID: 15788033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.